News
RGNT
1.490
-3.87%
-0.060
Regentis Biomaterials (NYSE American: RGNT) Reports Strong Surgeon Interest in GelrinC at International Cartilage Summit
TipRanks · 5d ago
Regentis Biomaterials (NYSE American: RGNT) to Present at 2026 ThinkEquity Conference on Oct. 15
TipRanks · 6d ago
Regentis Biomaterials reports ‘strong’ surgeon interest in GelrinC
TipRanks · 6d ago
Weekly Report: what happened at RGNT last week (1005-1009)?
Weekly Report · 10/12 10:35
Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City
Barchart · 10/09 15:05
Weekly Report: what happened at RGNT last week (0928-1002)?
Weekly Report · 10/05 10:34
Regentis Biomaterials Is Addressing the ‘Short-Term Relief, Long-Term Failure’ Problem in Knee Cartilage Repair
TipRanks · 10/02 16:00
Regentis Biomaterials and the Shift from Symptom Management to Structural Repair in Knee Cartilage Care
TipRanks · 09/29 16:30
Weekly Report: what happened at RGNT last week (0921-0925)?
Weekly Report · 09/28 10:28
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 09/21 17:06
Weekly Report: what happened at RGNT last week (0914-0918)?
Weekly Report · 09/21 10:28
Regentis Biomaterials (NYSE American: RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilage Repair
TipRanks · 09/14 16:30
Weekly Report: what happened at RGNT last week (0907-0911)?
Weekly Report · 09/14 10:34
Regentis Biomaterials Posts First-Half 2026 Results as GelrinC Trial Advances and Manufacturing Capacity Jumps
TipRanks · 09/11 13:47
Regentis Biomaterials H1 EPS $(0.44) Up From $(1.17) YoY
Benzinga · 09/11 13:16
Regentis Biomaterials reports 1H EPS (44c) vs. ($1.17) last year
TipRanks · 09/11 13:05
Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Barchart · 09/11 08:00
Weekly Report: what happened at RGNT last week (0831-0904)?
Weekly Report · 09/07 10:27
Weekly Report: what happened at RGNT last week (0824-0828)?
Weekly Report · 08/31 10:35
Regenerative Hydrogel Is Redefining Cartilage Repair as Regentis Advances GelrinC
TipRanks · 08/28 16:00
More
Webull provides a variety of real-time RGNT stock news. You can receive the latest news about Regentis Biomaterials Ltd through multiple platforms. This information may help you make smarter investment decisions.
About RGNT
Regentis Biomaterials Ltd is an Israel-based regenerative medicine company. The Company is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Its lead product is GellinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage. Its implant combines the precision of photopolymerization with the biocompatibility of PEG and fibrinogen, enabling natural tissue regeneration without the need for cell harvesting or culturing. Regentis Biomaterials Ltd aims to address unmet clinical needs in sports medicine and early-stage osteoarthritis.